Hikma confirms FTC preliminary approval for Custopharm
LONDON, April 20, 2022 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today confirms it has received preliminary approval from the US Federal Trade C...